Rethinking Drug Interactions and Bioavailability: How Valspodar Really Boosts Digoxin Plasma Levels
Enigmatic Historical Findings Defy Traditional Pharmacology Valspodar, a third-generation P-gp inhibitor developed all the way through Phase III clinical trials,


